Post-earnings recap
Reported
Thu, Feb 21, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's earnings report indicates a challenging quarter, as the company missed expectations on EPS. The stock reacted negatively, declining by 2.04%, likely due to the lack of revenue data and the absence of forward guidance. Investors may be concerned about the company's future performance without clear direction from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.03 | N/A | -218.01% |
| Revenue | N/A | N/A | N/A |
Management expressed a cautious outlook, emphasizing the importance of their pipeline. They did not offer specific guidance for the upcoming quarters.
Management did not provide specific guidance for future quarters.
The company is focused on ongoing product development and regulatory processes.